ANIXA BIOSCIENCES, INC. Accrued Liabilities, Current
ANIXA BIOSCIENCES, INC. (ANIX) had Accrued Liabilities, Current of $1.42 million as of 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-09-09
- 2026-07-31: Accrued Liabilities, Current $1.42M.
- 2026-04-30: Accrued Liabilities, Current $1.21M.
- 2026-01-31: Accrued Liabilities, Current $1.05M.
- 2025-10-31: Accrued Liabilities, Current $1.76M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-07-31 | $1.42M 10-Q · filed 2026-09-09 | |
| 2026-04-30 | $1.21M 10-Q · filed 2026-06-10 | |
| 2026-01-31 | $1.05M 10-Q · filed 2026-03-09 | |
| 2025-10-31 | $1.76M 10-Q · filed 2026-09-09 | |
| 2025-07-31 | $1.75M 10-Q · filed 2025-09-10 | |
| 2025-04-30 | $1.57M 10-Q · filed 2025-05-28 | |
| 2025-01-31 | $1.36M 10-Q · filed 2025-03-11 | |
| 2024-10-31 | $1.95M 10-K · filed 2026-01-12 | |
| 2024-07-31 | $1.68M 10-Q · filed 2024-09-06 | |
| 2024-04-30 | $1.41M 10-Q · filed 2024-06-04 | |
| 2024-01-31 | $1.24M 10-Q · filed 2024-03-12 | |
| 2023-10-31 | $1.77M 10-K · filed 2025-01-10 | |
| 2023-07-31 | $1.71M 10-Q · filed 2023-09-06 | |
| 2023-04-30 | $1.29M 10-Q · filed 2023-06-14 | |
| 2023-01-31 | $1.07M 10-Q · filed 2023-03-17 | |
| 2022-10-31 | $1.73M 10-K · filed 2024-01-16 | |
| 2022-07-31 | $1.20M 10-Q · filed 2022-09-09 | |
| 2022-04-30 | $1.06M 10-Q · filed 2022-06-10 | |
| 2022-01-31 | $1.24M 10-Q · filed 2022-03-11 | |
| 2021-10-31 | $1.09M 10-K · filed 2023-01-04 | $1.09M 10-K · filed 2022-01-04 |
| 2021-07-31 | $989.72K 10-Q · filed 2021-09-01 | |
| 2021-04-30 | $978.89K 10-Q · filed 2021-06-10 | |
| 2021-01-31 | $972.84K 10-Q · filed 2021-03-11 | |
| 2020-10-31 | $901.02K 10-K · filed 2022-01-04 | |
| 2020-07-31 | $815.72K 10-Q · filed 2020-09-08 | |
| 2020-04-30 | $850.15K 10-Q · filed 2020-06-09 | |
| 2020-01-31 | $705.03K 10-Q · filed 2020-03-09 | |
| 2019-10-31 | $895.50K 10-K · filed 2021-01-07 | |
| 2019-07-31 | $875.77K 10-Q · filed 2019-09-06 | |
| 2019-04-30 | $877.84K 10-Q · filed 2019-06-12 | |
| 2019-01-31 | $714.14K 10-Q · filed 2019-03-13 | |
| 2018-10-31 | $683.10K 10-K · filed 2020-01-09 | |
| 2018-07-31 | $710.06K 10-Q · filed 2018-09-07 | |
| 2018-04-30 | $888.15K 10-Q · filed 2018-06-11 | |
| 2018-01-31 | $669.63K 10-Q · filed 2018-03-09 | |
| 2017-10-31 | $409.17K 10-K · filed 2019-01-11 | |
| 2016-10-31 | $95.53K 10-K · filed 2018-01-09 | |
| 2013-07-31 | $691.27K 10-Q/A · filed 2013-09-20 | |
| 2013-04-30 | $609.95K 10-Q/A · filed 2013-06-19 | |
| 2013-01-31 | $582.06K 10-Q/A · filed 2013-03-25 | |
| 2012-10-31 | $330.62K 10-Q/A · filed 2013-09-20 | |
| 2012-07-31 | $129.87K 10-Q · filed 2012-09-14 | |
| 2012-04-30 | $139.99K 10-Q · filed 2012-06-14 | |
| 2012-01-31 | $161.56K 10-Q · filed 2012-03-16 | |
| 2011-10-31 | $85.78K 10-K · filed 2013-01-29 | |
| 2011-07-31 | $75.03K 10-Q/A · filed 2011-10-14 | |
| 2010-10-31 | $94.44K 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |